Latest Cinclus Pharma News & Updates

See the latest news and media coverage for Cinclus Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Cinclus Pharma

Clinical-stage pharmaceutical company

cincluspharma.com
Headquarters
Stockholm, Sweden
Founded year
2014
Company type
Private company
Number of employees
2–30

Last updated

Latest news about Cinclus Pharma

In short: Cinclus Pharma secured €28 million in financing and initiated Phase III clinical trials for its GERD drug candidate, linaprazan glurate.

Company announcements

  • Cinclus Pharma

    Cinclus Pharma publishes its 2025 Annual Report

    The report is available online in ESEF format. CEO highlights Phase III progress, Zentiva licensing, and China launch plans.

  • Cinclus Pharma

    Cinclus Pharma announces Annual General Meeting

    The meeting occurs on 21 May 2026 in Stockholm, covering board elections, incentives, and share issues. Proposals include re-elections, new board members, and a performance share program.

  • Cinclus Pharma

    Cinclus Pharma publishes interview with co-founder Kjell Andersson

    He talks about his career from Astra to founding the company and the start of the phase III study for linaprazan glurat 2025. The goal is global launch within five years.

  • Cinclus Pharma

    Cinclus Pharma enters EUR 28 million financing agreement

    The structured credit deal with Claret Capital Partners funds Phase III trials and pre-launch of linaprazan glurate. Initial EUR 8 million tranche drawn.

Unlock all announcements with a

Media coverage

  • Dagens industri

    Co-founder appears to have sold everything in Cinclus Pharma - at a big discount

    On Wednesday afternoon, Pareto brokered a position worth nearly 25 million kronor in Cinclus Pharma at a big discount. The share plummets 18 percent. In the newsletter Toppnyheter receives...

  • Marketscreener

    Cinclus Pharma's newly appointed CFO Magnus Christensen makes maiden share purchase | MarketScreener

    Magnus Christensen purchased 6,500 shares in the drug development company Cinclus Pharma on April 7, where he serves as Chief Financial Officer. The shares were...

  • Morningstar

    Cinclus Pharma Holding AB CINPHA

    Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive...

  • Marketscreener

    Cinclus Pharma secures financing of up to 28 million euros | MarketScreener

    The pharmaceutical development company Cinclus Pharma has entered into a financing agreement with Claret Capital Partners for up to 28 million euros. The capital will...

Unlock all articles with a

Never miss news about Cinclus Pharma

Track Cinclus Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.